Logo Valence
Populaire
Se connecter
Loading data for XPH — first visit, this takes a few seconds.

Ajouter à la liste de suivi

State Street SPDR S&P Pha...

NYSEArca: XPH · Prix en temps réel · USD
72.45
+2.03 (2.88%)
À la clôture : Aug 18, 2026, 8:00 PM
73.09
+0.89%
Préouverture: 8:16 AM

State Street SPDR S&P Pharmaceuticals ETF (XPH) ETF Price, Holdings & Analysis

2.88%

Aucune donnée disponible

Bid0
Capitalisation boursièren/a
AUM489.39M
NAV70.50
Bêta0.7
EPS (ttm)n / A
Rapport PE (ttm)19.15
Parts en circulation5.5M
Date de créationJun 19, 2006
Ask0
Volume121,770
Moy. Volume (20D)95,196
Ouverture71.10
Clôture précédente70.42
Fourchette du jour71.06 - 72.48
Intervalle de 52 semaines45.80 - 72.49
Positionsn / A
Ratio de frais0.35%

À propos de XPH

In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

Classe d’actifs Equity
Symbole boursier XPH
Date de création Jun 19, 2006
Fournisseur State Street Investment Management
Site web Page d’accueil du fonds
Échange NYSEArca

Principaux secteurs

SecteurPoids %
Healthcare100.00%
Voir tous les secteurs

10 principaux titres 25.66% des actifs

NomSymbolePoids
Crinetics Pharmaceut...CRNX3.69%
Mbx Biosciences IncMBX3.22%
Ataibeckley IncATAI2.88%
Definium Therapeutic...DFTX2.84%
Amylyx Pharmaceutica...AMLX2.29%
Enliven Therapeutics...ELVN2.24%
Corcept Therapeutics...CORT2.22%
Alumis IncALMS2.13%
Nuvation Bio Inc Ord...NUVB2.09%
Trevi Therapeutics I...TRVI2.06%
Voir plus de titres

Dividendes Rendement du dividende 0.46%

Ex-dividendeMontantDate de paiement
Jun 22, 2026$0.0590n / A
Mar 23, 2026$0.0610n / A
Dec 22, 2025$0.1130n / A
Sep 22, 2025$0.1030n / A
Jun 23, 2025$0.0960n / A
Historique complet des dividendes
news image

1 semaine il y a · Zacks

Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Smart Beta ETF report for XPH

news image

1 semaine il y a · Zacks

Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

news image

2 semaines il y a · Barrons.com

8 ETF Winners in the ‘Pay Me Now’ Trade

Investors looking for stability should buy these funds focused on companies with strong sales, healthy dividends, and cash flow.

news image

5 mois il y a · 24/7 Wall St.

These 5 Undervalued ETFs Could Be Bargains Right Now

Not every exchange-traded fund (ETF) worth owning trades at a premium. Some of the most structurally sound funds sit quietly below the radar, offering low costs, reliable income, or sector exposure th...

news image

6 mois il y a · 24/7 Wall St.

XPH’s 29% Run Looks Tempting, But The 5y Chart Is A Warning

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) exists to solve a specific problem: how do you gain broad exposure to pharmaceutical companies without the concentration risk of the largest healthcare name...

Page 1 de 2